Cantex Pharmaceuticals
Under Construction
- Employees
- 1–10
- Founded
- 2007
- Business Model
- B2B
- Website
- cantex.com
About
Cantex Pharmaceuticals, Inc. is a privately held, clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed. Cantex is developing azeliragon, an oral inhibitor of the receptor for advanced glycation end products (known as RAGE). The company has ongoing Phase 2 clinical trials in glioblastoma, brain metastasis, metastatic pancreatic cancer, and breast cancer, plus a Phase 3 trial in hospitalized patients with pneumonia.
Summary
Cantex Pharmaceuticals is a Biotech company, founded in 2007.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cantex-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/cantex-pharmaceuticals" alt="Cantex Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>